Skip to main content

Soleus Capital Management, L.P.

Position in TGTX — Tg Therapeutics, Inc.

CIK 1802630 GREENWICH, CT

Position in TGTX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$133,853,977
+$40,271,087 QoQ
Shares Held
4,029,319
+28.4% QoQ
Ownership
2.63%
of shares outstanding
% of Portfolio
5.42%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,377,926,099 across 59 Biotechnology names. TGTX ranks #3 (9.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 TGTX
Tg Therapeutics, Inc.
This page
4,029,319 $133,853,977

All Filings in TGTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $133,853,977 4,029,319
2025-12-31 $93,582,890 3,139,312
2025-09-30 $138,890,907 3,844,731
2025-06-30 $80,759,220 2,243,935
2025-03-31 $112,245,499 2,846,703
2024-12-31 $80,705,384 2,681,242
2024-09-30 $59,282,890 2,534,540
2024-06-30 $64,854,547 3,645,562
2024-03-31 $48,192,215 3,168,456
2023-12-31 $11,102,000 650,000
2023-09-30 $24,113,433 2,884,382
2023-06-30 $10,817,820 435,500
2023-03-31 $11,284,512 750,300
2022-12-31 $2,815,540 238,000